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Purpose: Chronic heart failure (CHF) is a condition characterized by multiple debilitating 
symptoms that impact patient quality of life. The present study aims to explore the 
prevalence and severity of nine symptoms commonly associated with CHF and investigate 
their impact on quality of life. 
Methods: One hundred and eleven inpatients and outpatients with symptomatic CHF were 
recruited from St Vincent’s Hospital, Sydney. Prevalence and severity of nine symptoms 
were assessed using the Edmonton Symptom Assessment System (ESAS), quality of life 
(QOL) was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ), 
functional status was measured using the Australian modified Karnosfky Permance Scale 
(AKPS), and depressive symptoms with the Patient Health Questionnaire (PHQ-9). Multiple 
linear regression analyses were used to examine the effect of clinical and demographic 
variables, and symptom burden on QOL. 
Results: In this young but symptomatic cohort, (58±15 years, 78% male, 52% ≥ NYHA class 
III), tiredness (62%), breathlessness (58%), and loss of wellbeing (57%) were most frequently 
reported and perceived as the most severe symptoms. Controlling for age, sex, comorbidity, 
and LVEF, predictors of QOL were social limitation (B=0.458, p<0.001), depressive symptoms 
(B=-0.234, p=0.035), and functional status (B=0.282, p=0.001). Overall, this model explained 
64% of the variance of QOL in this cohort. Those patients who had the most symptom 
burden (higher overall ESAS scores) had worse event-free survival (all-cause mortality or 
rehospitalisation) within 6 months. 
 
Conclusions: People with CHF often do not experience one symptom in isolation, but rather 
experience multiple symptoms. Continued evaluation and management of all symptoms 
may help to improve quality of life and outcomes. 
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